Next Article in Journal
A Survey of Methodologies for Assessing Mast Cell Density and Activation in Patients with Functional Abdominal Pain Disorders
Previous Article in Journal
Sustained Crohn’s Disease Remission with an Exclusive Elemental and Exclusion Diet: A Case Report
Opinion

Crohn’s Disease: The infectious Disease Incorporated’s Perspective

Infectious Diseases Incorporated, Bellevue, NE 68123, USA
Academic Editors: John F. Mayberry and Andrew Day
Gastrointest. Disord. 2021, 3(3), 138-141; https://0-doi-org.brum.beds.ac.uk/10.3390/gidisord3030015
Received: 21 June 2021 / Revised: 7 August 2021 / Accepted: 13 August 2021 / Published: 25 August 2021
(This article belongs to the Special Issue Crohn's Disease: Symptoms, Causes, Management and Treatment)
Infectious Diseases Incorporated (IDI) is an infectious disease think-tank, established in 1973. Crohn’s disease (CD) is a chronic, recurrent disease of the gastrointestinal tract that has reached epidemic proportions within industrialized nations. CD is said to be without cure. Since 2003, therapeutic interventions have focused on disruption of the pro-inflammatory Th1 response against an unknown antigen. In 2015, the Hruska Postulate was introduced and, in so doing, explained how, in the absence of acquired immunity, newborn infection by Mycobacterium avium subspecies paratuberculosis could cause fixation of the immune system’s Th1 response against the organism. The Hruska Postulate was utilized to answer all the documented epidemiological facts embedded in the natural history of Crohn’s disease and, in particular, why breastfeeding confers protection against the future development of Crohn’s disease. It is Infectious Diseases Incorporated’s (IDI) stated opinion that Crohn’s disease is both preventable and curable if treated appropriately in its early stages. View Full-Text
Keywords: Crohn’s disease; Hruska Postulate; Mycobacterium avium subspecies paratuberculosis; autoimmunity Crohn’s disease; Hruska Postulate; Mycobacterium avium subspecies paratuberculosis; autoimmunity
MDPI and ACS Style

Monif, G.R.G. Crohn’s Disease: The infectious Disease Incorporated’s Perspective. Gastrointest. Disord. 2021, 3, 138-141. https://0-doi-org.brum.beds.ac.uk/10.3390/gidisord3030015

AMA Style

Monif GRG. Crohn’s Disease: The infectious Disease Incorporated’s Perspective. Gastrointestinal Disorders. 2021; 3(3):138-141. https://0-doi-org.brum.beds.ac.uk/10.3390/gidisord3030015

Chicago/Turabian Style

Monif, Gilles R.G. 2021. "Crohn’s Disease: The infectious Disease Incorporated’s Perspective" Gastrointestinal Disorders 3, no. 3: 138-141. https://0-doi-org.brum.beds.ac.uk/10.3390/gidisord3030015

Find Other Styles

Article Access Map by Country/Region

1
Back to TopTop